Xiaoning Wu

1.8k total citations · 1 hit paper
72 papers, 982 citations indexed

About

Xiaoning Wu is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Xiaoning Wu has authored 72 papers receiving a total of 982 indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Epidemiology, 43 papers in Hepatology and 7 papers in Surgery. Recurrent topics in Xiaoning Wu's work include Liver Disease Diagnosis and Treatment (39 papers), Hepatitis B Virus Studies (32 papers) and Hepatitis C virus research (21 papers). Xiaoning Wu is often cited by papers focused on Liver Disease Diagnosis and Treatment (39 papers), Hepatitis B Virus Studies (32 papers) and Hepatitis C virus research (21 papers). Xiaoning Wu collaborates with scholars based in China, United States and Singapore. Xiaoning Wu's co-authors include Hong You, Jidong Jia, Yameng Sun, Xiaojuan Ou, Jialing Zhou, Yuanyuan Kong, Arie Abo, Earl T. Sawai, Haifeng Yu and B. Matija Peterlin and has published in prestigious journals such as Nature Communications, PLoS ONE and Hepatology.

In The Last Decade

Xiaoning Wu

66 papers receiving 958 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019

2024 53 citations Xiaoning Wu, Feng Xue et al. BMC Public Health profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoning Wu China	17	569	427	130	106	95	72	982
Pier Luigi Calvo Italy	19	790 1.4×	892 2.1×	112 0.9×	243 2.3×	40 0.4×	72	1.3k
Alessandro Perrella Italy	18	560 1.0×	415 1.0×	137 1.1×	133 1.3×	31 0.3×	92	1.2k
Hirofumi Ohashi Japan	19	329 0.6×	225 0.5×	156 1.2×	205 1.9×	40 0.4×	82	1.1k
Yoshihiko Yano Japan	23	1.0k 1.8×	897 2.1×	204 1.6×	151 1.4×	26 0.3×	152	1.7k
Piétro Scalfaro Switzerland	17	576 1.0×	576 1.3×	488 3.8×	83 0.8×	176 1.9×	35	1.4k
H Hartmann Germany	18	569 1.0×	472 1.1×	167 1.3×	173 1.6×	30 0.3×	71	1.1k
Liliana Preiss United States	15	211 0.4×	183 0.4×	42 0.3×	46 0.4×	82 0.9×	44	855
C Sato Japan	16	750 1.3×	952 2.2×	195 1.5×	43 0.4×	43 0.5×	33	1.3k
Marie‐Claude Gagnieu France	19	273 0.5×	239 0.6×	169 1.3×	97 0.9×	71 0.7×	63	889
Kelly Kaita Canada	19	887 1.6×	756 1.8×	111 0.9×	115 1.1×	14 0.1×	49	1.2k

Countries citing papers authored by Xiaoning Wu

Since Specialization

Citations

This map shows the geographic impact of Xiaoning Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoning Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoning Wu more than expected).

Fields of papers citing papers by Xiaoning Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoning Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoning Wu. The network helps show where Xiaoning Wu may publish in the future.

Co-authorship network of co-authors of Xiaoning Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoning Wu. A scholar is included among the top collaborators of Xiaoning Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoning Wu. Xiaoning Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Can, et al.. (2024). Physical Restraint Experience of Patients with Mental Disorders in Mainland China: A Qualitative Study. Journal of Multidisciplinary Healthcare. Volume 17. 431–444. 1 indexed citations

Zhang, Ning, Xiaoning Wu, Yameng Sun, et al.. (2024). Targeting thrombospondin-2 retards liver fibrosis by inhibiting TLR4-FAK/TGF-β signaling. JHEP Reports. 6(3). 101014–101014. 8 indexed citations

Wang, Yanbo, et al.. (2024). Development of a Questionnaire for Measuring Trauma-Informed Care of Nurses Working with Traumatically Injured Patients. Journal of Multidisciplinary Healthcare. Volume 17. 367–378. 1 indexed citations

Li, Ye, et al.. (2024). Sevoflurane blocks KLF5‐mediated transcriptional activation of ITGB2 to inhibit macrophage infiltration in hepatic ischemia/reperfusion injury. The Journal of Gene Medicine. 26(5). e3692–e3692. 1 indexed citations

Wu, Xiaoning, Feng Xue, Nan Zhang, et al.. (2024). Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019. BMC Public Health. 24(1). 363–363. 53 indexed citations breakdown →

Chen, Wei, Yameng Sun, Shuyan Chen, et al.. (2023). Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities. Hepatology. 78(4). 1118–1132. 15 indexed citations

Chen, Qian, Yuxuan Liu, Yu Tian, Xiaoning Wu, & Hongbao Zhang. (2023). Quench dynamics in holographic first-order phase transition. Physical review. D. 108(10). 8 indexed citations

Li, Ye, et al.. (2023). Sevoflurane Preconditioning Downregulates GRIA1 Expression to Attenuate Cerebral Ischemia–Reperfusion-Induced Neuronal Injury. Neurotoxicity Research. 41(1). 29–40. 6 indexed citations

Wang, Can, et al.. (2023). Psychiatric Nurses’ Knowledge, Attitudes, and Practice Regarding Physical Restraint in China: A Multicentre Cross-Sectional Study. Journal of Multidisciplinary Healthcare. Volume 16. 1475–1489. 2 indexed citations

10.

Wang, Qianyi, Xinyan Zhao, Yameng Sun, et al.. (2022). Histological assessment based on liver biopsy: the value and challenges in NASH drug development. Acta Pharmacologica Sinica. 43(5). 1200–1209. 23 indexed citations

11.

Zhao, Xinyu, Min� Li, Hao Wang, et al.. (2022). Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China. Journal of Clinical and Translational Hepatology. 10(3). 420–428. 6 indexed citations

12.

Wu, Xiaoning, Jialing Zhou, Yameng Sun, et al.. (2021). Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis. Hepatology International. 15(6). 1318–1327. 11 indexed citations

13.

Sun, Yameng, Xiaoning Wu, Jialing Zhou, et al.. (2020). Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy. Clinical Gastroenterology and Hepatology. 18(11). 2582–2591.e6. 72 indexed citations

14.

Wu, Xiaoning, et al.. (2020). Comparison of a novel chemiluminescence immunoassay with the passive agglutination method for the diagnosis of Mycoplasma pneumoniae infection in children. Journal of Microbiological Methods. 173. 105921–105921. 11 indexed citations

15.

Wu, Xiaoning, Jialing Zhou, Wen Xie, et al.. (2019). <p>Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study</p>. Infection and Drug Resistance. Volume 12. 745–757. 8 indexed citations

16.

Sun, Yameng, Jialing Zhou, Xiaoning Wu, et al.. (2018). Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak “stable” patients on anti-HBV therapy. Scientific Reports. 8(1). 2989–2989. 32 indexed citations

17.

Zhang, Wei, Xiaomin Wang, Yu Wang, et al.. (2017). Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B. Medicine. 96(44). e8454–e8454. 14 indexed citations

18.

Wu, Xiaoning, Lianqiu Min, Yujie Jia, et al.. (2013). Sex differences in health-related quality of life among adult stroke patients in Northeastern China. Journal of Clinical Neuroscience. 21(6). 957–961. 24 indexed citations

19.

Lü, Xiaobin, Xiaoning Wu, Ana Plemenitaš, et al.. (1996). CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. Current Biology. 6(12). 1677–1684. 120 indexed citations

20.

Feldman, S. A., Xiaoning Wu, & A. J. England. (1995). Rate of‘onset’ and‘offset’ of four non‐depolarising neuromuscular blocking drugs. Anaesthesia. 50(6). 510–513. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact